Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $369.84 | 6 | 96.6% |
| Education | $13.13 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $121.61 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $93.35 | 1 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $85.07 | 1 | $0 (2023) |
| ABBVIE INC. | $26.31 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $23.19 | 1 | $0 (2024) |
| Horizon Therapeutics plc | $20.31 | 1 | $0 (2021) |
| PFIZER INC. | $13.13 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.50 | 2 | ABBVIE INC. ($26.31) |
| 2023 | $300.03 | 3 | NOVARTIS PHARMACEUTICALS CORPORATION ($121.61) |
| 2021 | $33.44 | 2 | Horizon Therapeutics plc ($20.31) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $93.35 | General |
| Category: Rare Disease | ||||||
| 11/11/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $121.61 | General |
| 04/25/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $85.07 | General |
| Category: Cardiology | ||||||
| 12/31/2021 | PFIZER INC. | XELJANZ (Drug) | Education | In-kind items and services | $13.13 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/04/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 240 | 421 | $55,273 | $28,566 |
| 2022 | 6 | 253 | 432 | $66,727 | $30,519 |
| 2021 | 6 | 262 | 437 | $79,390 | $32,207 |
| 2020 | 6 | 267 | 402 | $54,841 | $23,122 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 155 | 327 | $41,529 | $21,677 | 52.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 35 | $6,230 | $3,684 | 59.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $3,196 | $1,502 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 25 | 26 | $2,340 | $1,131 | 48.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 13 | 16 | $1,978 | $572.40 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 143 | 298 | $43,727 | $19,753 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 36 | 55 | $11,220 | $5,406 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $3,572 | $1,870 | 52.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $3,237 | $1,627 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 28 | 30 | $3,090 | $1,292 | 41.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2022 | 14 | 17 | $1,881 | $571.23 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 140 | 294 | $49,882 | $20,499 | 41.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 40 | 55 | $13,566 | $5,506 | 40.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 31 | 31 | $6,858 | $2,770 | 40.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $4,323 | $1,591 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 24 | 28 | $3,564 | $1,294 | 36.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2021 | 16 | 18 | $1,197 | $548.36 | 45.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 126 | 223 | $28,703 | $11,956 | 41.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 54 | 79 | $14,533 | $6,235 | 42.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 33 | 33 | $6,369 | $2,635 | 41.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 18 | 23 | $1,863 | $943.17 | 50.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 20 | 21 | $1,848 | $680.14 | 36.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2020 | 16 | 23 | $1,525 | $672.64 | 44.1% |
About Dr. Jonathan Jones, MD
Dr. Jonathan Jones, MD is a Rheumatology healthcare provider based in Corvallis, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003868720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Jones, MD has received a total of $382.97 in payments from pharmaceutical and medical device companies, with $49.50 received in 2024. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($369.84).
As a Medicare-enrolled provider, Jones has provided services to 1,022 Medicare beneficiaries, totaling 1,692 services with total Medicare billing of $114,414. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Corvallis, OR
- Active Since 05/17/2006
- Last Updated 11/10/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1003868720
Products in Payments
- STRENSIQ (Biological) $93.35
- UPTRAVI (Drug) $85.07
- RINVOQ (Biological) $26.31
- BENLYSTA (Biological) $23.19
- KRYSTEXXA (Biological) $20.31
- XELJANZ (Drug) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.